These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 1377359

  • 1. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.
    Cardiac Arrhythmia Suppression Trial II Investigators.
    N Engl J Med; 1992 Jul 23; 327(4):227-33. PubMed ID: 1377359
    [Abstract] [Full Text] [Related]

  • 2. Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST).
    Anderson JL, Platia EV, Hallstrom A, Henthorn RW, Buckingham TA, Carlson MD, Carson PE.
    Circulation; 1994 Dec 23; 90(6):2843-52. PubMed ID: 7994829
    [Abstract] [Full Text] [Related]

  • 3. Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST).
    Epstein AE, Hallstrom AP, Rogers WJ, Liebson PR, Seals AA, Anderson JL, Cohen JD, Capone RJ, Wyse DG.
    JAMA; 1993 Nov 24; 270(20):2451-5. PubMed ID: 8230622
    [Abstract] [Full Text] [Related]

  • 4. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.
    Cardiac Arrhythmia Suppression Trial (CAST) Investigators.
    N Engl J Med; 1989 Aug 10; 321(6):406-12. PubMed ID: 2473403
    [Abstract] [Full Text] [Related]

  • 5. Predicting mortality after myocardial infarction from the response of RR variability to antiarrhythmic drug therapy.
    Bigger JT, Rolnitzky LM, Steinman RC, Fleiss JL.
    J Am Coll Cardiol; 1994 Mar 01; 23(3):733-40. PubMed ID: 7509355
    [Abstract] [Full Text] [Related]

  • 6. The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II.
    Greene HL, Roden DM, Katz RJ, Woosley RL, Salerno DM, Henthorn RW.
    J Am Coll Cardiol; 1992 Apr 01; 19(5):894-8. PubMed ID: 1552108
    [Abstract] [Full Text] [Related]

  • 7. The Cardiac Arrhythmia Suppression Trial: Implications for nursing practice.
    Kellen JC, Ettinger A, Todd L, Brezsnyak ML, Campion J, McBride R, Thomas S, Corum J, Schron E.
    Am J Crit Care; 1996 Jan 01; 5(1):19-25. PubMed ID: 8680488
    [Abstract] [Full Text] [Related]

  • 8. Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in the entire population enrolled.
    Epstein AE, Bigger JT, Wyse DG, Romhilt DW, Reynolds-Haertle RA, Hallstrom AP.
    J Am Coll Cardiol; 1991 Jul 01; 18(1):14-9. PubMed ID: 1904891
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association between ease of suppression of ventricular arrhythmia and survival.
    Goldstein S, Brooks MM, Ledingham R, Kennedy HL, Epstein AE, Pawitan Y, Bigger JT.
    Circulation; 1995 Jan 01; 91(1):79-83. PubMed ID: 7805221
    [Abstract] [Full Text] [Related]

  • 11. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
    Cardiac Arrhythmia Pilot Study (CAPS) InvestigatorsThe CAPS Coordinating Center, University of Washington, JD-22, 1107 Northeast 45th, Room 505, Seattle, Washington 98105, USA..
    Am J Cardiol; 1988 Mar 01; 61(8):501-9. PubMed ID: 2894169
    [Abstract] [Full Text] [Related]

  • 12. Effects of advancing age on the efficacy and side effects of antiarrhythmic drugs in post-myocardial infarction patients with ventricular arrhythmias. The CAST Investigators.
    Akiyama T, Pawitan Y, Campbell WB, Papa L, Barker AH, Rubbert P, Friedman L, Keller M, Josephson RA.
    J Am Geriatr Soc; 1992 Jul 01; 40(7):666-72. PubMed ID: 1607582
    [Abstract] [Full Text] [Related]

  • 13. Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST Investigators.
    Akiyama T, Pawitan Y, Greenberg H, Kuo CS, Reynolds-Haertle RA.
    Am J Cardiol; 1991 Dec 15; 68(17):1551-5. PubMed ID: 1720917
    [Abstract] [Full Text] [Related]

  • 14. Moricizine: a new class I antiarrhythmic.
    Mann HJ.
    Clin Pharm; 1990 Nov 15; 9(11):842-52. PubMed ID: 2272151
    [Abstract] [Full Text] [Related]

  • 15. Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST).
    Peters RW, Mitchell LB, Brooks MM, Echt DS, Barker AH, Capone R, Liebson PR, Greene HL.
    J Am Coll Cardiol; 1994 Feb 15; 23(2):283-9. PubMed ID: 8294678
    [Abstract] [Full Text] [Related]

  • 16. Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study).
    Greene HL, Richardson DW, Barker AH, Roden DM, Capone RJ, Echt DS, Friedman LM, Gillespie MJ, Hallstrom AP, Verter J.
    Am J Cardiol; 1989 Jan 01; 63(1):1-6. PubMed ID: 2462341
    [Abstract] [Full Text] [Related]

  • 17. A critical appraisal of the cardiac arrhythmia suppression trial (CAST).
    Naccarelli GV, Dougherty AH, Wolbrette D, Wiggins S.
    Appl Cardiopulm Pathophysiol; 1991 Jan 01; 4(1):9-16. PubMed ID: 10147539
    [Abstract] [Full Text] [Related]

  • 18. Implications of the Cardiac Arrhythmia Suppression Trial for antiarrhythmic drug treatment.
    Bigger JT.
    Am J Cardiol; 1990 Feb 20; 65(8):3D-10D; discussion 68D-71D. PubMed ID: 2106253
    [Abstract] [Full Text] [Related]

  • 19. Relation of baseline characteristics to suppression of ventricular arrhythmias during placebo and active antiarrhythmic therapy in patients after myocardial infarction.
    Anderson JL, Hallstrom AP, Griffith LS, Ledingham RB, Reiffel JA, Yusuf S, Barker AH, Fowles RE, Young JB.
    Circulation; 1989 Mar 20; 79(3):610-9. PubMed ID: 2465099
    [Abstract] [Full Text] [Related]

  • 20. Moricizine and quality of life in the Cardiac Arrhythmia Suppression Trial II (CAST II).
    Brooks MM, Gorkin L, Schron EB, Wiklund I, Campion J, Ledingham RB.
    Control Clin Trials; 1994 Dec 20; 15(6):437-49. PubMed ID: 7851106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.